SynCore Biotechnology Co Ltd (4192) — Long-term Investment Intensity
SynCore Biotechnology Co Ltd (4192) has a Long-term Investment Intensity of 4.0% as of December 2019. Long-term investments of NT$30.39 Million represent 4.0% of total assets of NT$763.88 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check SynCore Biotechnology Co Ltd (4192) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SynCore Biotechnology Co Ltd Long-term Investment Intensity (2015–2019)
This chart shows how SynCore Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 4.0%, reflecting long-term investments of NT$30.39 Million against total assets of NT$763.88 Million TWD. For the complete balance sheet picture, see SynCore Biotechnology Co Ltd assets under control.
Annual Long-term Investment Intensity for SynCore Biotechnology Co Ltd (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for SynCore Biotechnology Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read SynCore Biotechnology Co Ltd total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.0% | NT$30.39 Million | NT$763.88 Million | ▼ -3.3 pp |
| 2018 | 7.3% | NT$58.87 Million | NT$804.80 Million | ▼ -4.8 pp |
| 2017 | 12.1% | NT$102.65 Million | NT$845.89 Million | ▲ +4.0 pp |
| 2016 | 8.1% | NT$90.44 Million | NT$1.11 Billion | ▼ -15.1 pp |
| 2015 | 23.2% | NT$238.34 Million | NT$1.03 Billion | — |